沈迎,张瑞岩,沈卫峰

• 1:上海交通大学医学院附属瑞金医院心脏科

摘要(Abstract)：

<正>毫无疑义,经过近30多年的研究,我们对急性ST段抬高心肌梗死(STEMI)的发病机制和再灌注策略有了深刻的认识。冠状动脉血栓性完全阻塞是STEMI的主要病因,为此,2013年美国心脏病学会基金会(ACCF)/美国心脏协会(AHA)STEMI处理指南[1]、2012年欧洲心脏病学会(ESC)急性STEMI患者处理指南[2]和2010年急性心肌梗死诊断和治

关键词(KeyWords)： 急性心肌梗死;经皮冠状动脉介入治疗;血栓抽吸;辅助循环;抗栓治疗

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 沈迎,张瑞岩,沈卫峰

参考文献(References)：

• [1]O'Gara PT,Kushner FG,Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction.A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation,2013,127:e362-e425.
• [2]Steg PG,James SK,Atar D,et al.ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.Task Force on the management of STsegment elevation acute myocardial infarction of the European Society of Cardiology(ESC).Eur Heart J,2012,33:2569-2619.
• [3]中华医学会心血管病分会,中华心血管病杂志编辑委员会.急性心肌梗死诊断和治疗指南.中华心血管病杂志,2010,38:675-690.
• [4]Wald DS,Morris JK,Wald NJ,et al.Randomized trial of preventive angioplasty in myocardial infarction.N Engl J Med,2013,369:1115-1123.
• [5]Kelly DJ,Mc Cann GP,Blackman D,et al.Complete Versus culprit-Lesion only Primary PCI Trial(CVLPRIT):a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI:rationale and design.Euro Intervention,2013,8:1190-1198.
• [6]Manari A,Varani E,Guastaroba P,et al.Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only,immediate,or staged multivessel percutaneous revascularization strategies:Insights from the REAL registry.Catheter Cardiovasc Interv,2014,84:912-922.
• [7]Hannan EL,Samadashvili Z,Walford G,et al.Staged versus one-time complete revascularization with percutaneous coronary intervention for multivessel coronary artery disease patients without ST-elevation myocardial infarction.Circ Cardiovasc Interv,2013,6:12-20.
• [8]Vlaar PJ,Svilaas T,van der Horst IC,et al.Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study(TAPAS):a 1-year follow-up study.Lancet,2008,371:1915-1920.
• [9]Noman A,Fgred M,Bagnall A,et al.Impact of thrombus aspiration during primary percutaneous coronary intervention on mortality in ST-segment elevation myocardial infarction.Eur Heart J,2012,33:3054-3061.
• [10]顾崇怀,邓宇阳,杨晓旭,等.血栓抽吸的应用现状及应用.中国介入中脏病学杂志,2014,22:462-464.
• [11]Frobert O,Lagerqvist B,Olivecrona GK,et al.Thrombus aspiration during ST-segment elevation myocardial infarction.N Engl J Med,2013,369:1587-1597.
• [12]Fernandez-Rodriguez D,Regueiro A,Brugaletta S,et al.Optimization in stent implantation by thrombus aspiration in STsegment elevation myocardial infarction:findings from the EXAMINATION trial.Circ Cardiovasc Interv,2014,7:294-300.
• [13]Zhu TQ,Zhang Q,Qiu JP,et al.Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention:the ICT-AMI study.Int J Cardiol,2013,165:437-443.
• [14]Boscarelli D,Vaquerizo B,Miranda-Guardiola F,et al.Intracoronary thrombolysis in patients with ST-segment elevation myocardial infarction presenting with massive intraluminal thrombus and failed aspiration.Eur Heart J Acute Cardiovasc Care,2014,3:229-236.
• [15]Zhu TQ,Zhang Q,Ding FH,et al.Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute STelevation myocardial infarction:results of the ICTUS-AMI trial.Chin Med J(Engl),2013,126:3079-3086.
• [16]Khashan MY,Pinsky MR.Does intra-aortic balloon support for myocardial infarction with cardiogenic shock improve outcome?Crit Care,2013,17:307.
• [17]Thiele H,Zeymer U,Neumann FJ,et al.Intraaortic Balloon Pump in cardiogenic shockⅡ(IABP-SHOCKⅡ)trial investigators.Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock(IABPSHOCKⅡ):final 12 month results of a randomised,open-label trial.Lancet,2013,382:1638-1645.
• [18]Sjauw KD,Engstrom AE,Vis MM,et al.Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock.Neth Heart J,2012,20:402-409.
• [19]Sjauw KD,Engstrom AE,Vis MM,et al.A systematic review and meta-analysis of intra-aortic balloon pump therapy in STelevation myocardial infarction:should we change the guidelines?Eur Heart J,2009,30:459-468.
• [20]Lee MS,Wolfe M,Stone GW.Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes:re-evaluation of the current body of evidence.JACC Cardiovasc Interv,2013,6:1149-1152.
• [21]Karrowni W,Vyas A,Giacomino B,et al.Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients:a meta-analysis of randomized controlled trials.JACC Cardiovasc Interv,2013,6:814-823.
• [22]Stone GW,Witzenbichler B,Guagliumi G,et al.HORIZONSAMI Trial Investigators.Bivalirudin during primary PCI in acute myocardial infarction.N Engl J Med,2008,358:2218-2230.
• [23]Mamas MA,Anderson SG,Ratib K,et al.Arterial access site utilization in cardiogenic shock in the United Kingdom:is radial access feasible?Am Heart J,2014,167:900-908.
• [24]Zhang Q,Qiu JP,Zhang RY,et al.Improved outcomes from transradial over transfemoral access in primary percutaneous coronary intervention for patients with acute ST-segment elevation myocardial infarction and upstream use of tirofiban.Chin Med J(Engl),2013,126:1063-1068.
• [25]Wallentin L,Becker RC,Cannon CP,et al.No misrepresentation of vital status follow-up in PLATO:predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial:Commentary on:Di Nicolantonio JJ,Tomek A,Misrepresentation of vital status follow-up:challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel,International Journal of Cardiology,2013 Serebruany VL.Discrepancies in the primary PLATO trial publication and the FDA reviews,International Journal of Cardiology,2014.Int J Cardiol,2014,176:300-302.
• [26]Montalescot G,van't Hof AW,Lapostolle F,et al.Prehospital ticagrelor in ST-segment elevation myocardial infarction.N Engl J Med,2014,371:1016-1027.
• [27]Zeymer U,van't Hof A,Adgey J,et al.Bivalirudin is superior to heparin alone with bailout GPⅡb/Ⅲa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention:a pre-specified analysis from the EUROMAX trial.Eur Heart J,2014,35:2460-2467.
• [28]Shahzad A.How effective are antithrombotic therapies in PPCI(HEAT PPCI).Washington,DC.The American College of Cardiology(ACC)/i2 annual Scientific Session,2014.
• [29]颜红兵,霍勇.急性心肌梗死介入治疗临床研究进展.中国介入心脏病学杂志,2014,22:642-646.